Teruo Nishida1, Ryoji Yanai. 1. Department of Ophthalmology, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan. tnishida@yamaguchi-u.ac.jp
Abstract
PURPOSE OF REVIEW: To review the clinical characteristics and possible new mode of treatments for the corneal epithelial disorders associated with neurotrophic keratopathy. RECENT FINDINGS: The successful clinical applications of eyedrops containing substance P and insulin-like growth factor-1, or peptides derived therefrom, were reported for the treatment of humans with neurotrophic keratopathy. SUMMARY: Neurotrophic keratopathy, a degenerative disease of the cornea, is caused by an impairment of function of the trigeminal nerve and an insufficient supply of neural factors. The combination of substance P, a sensory neurotransmitter, and insulin-like growth factor-1 induced a synergistic stimulatory effect on corneal epithelial migration as well as on corneal wound closure in vivo. We discuss the roles of growth factors and substance P, a sensory neurotransmitter released from the trigeminal nerve, in corneal epithelial wound healing as well as the clinical application of these molecules to the treatment of neurotrophic keratopathy.
PURPOSE OF REVIEW: To review the clinical characteristics and possible new mode of treatments for the corneal epithelial disorders associated with neurotrophic keratopathy. RECENT FINDINGS: The successful clinical applications of eyedrops containing substance P and insulin-like growth factor-1, or peptides derived therefrom, were reported for the treatment of humans with neurotrophic keratopathy. SUMMARY:Neurotrophic keratopathy, a degenerative disease of the cornea, is caused by an impairment of function of the trigeminal nerve and an insufficient supply of neural factors. The combination of substance P, a sensory neurotransmitter, and insulin-like growth factor-1 induced a synergistic stimulatory effect on corneal epithelial migration as well as on corneal wound closure in vivo. We discuss the roles of growth factors and substance P, a sensory neurotransmitter released from the trigeminal nerve, in corneal epithelial wound healing as well as the clinical application of these molecules to the treatment of neurotrophic keratopathy.
Authors: Pedram Hamrah; Andrea Cruzat; Mohammad H Dastjerdi; Lixin Zheng; Bashar M Shahatit; Hasan A Bayhan; Reza Dana; Deborah Pavan-Langston Journal: Ophthalmology Date: 2010-09-01 Impact factor: 12.079
Authors: Hongmin Yun; Michael B Yee; Kira L Lathrop; Paul R Kinchington; Robert L Hendricks; Anthony J St Leger Journal: Immunity Date: 2020-11-17 Impact factor: 31.745
Authors: Mehrnoosh Saghizadeh; Andrei A Kramerov; Fu-Shin X Yu; Maria G Castro; Alexander V Ljubimov Journal: Invest Ophthalmol Vis Sci Date: 2009-11-20 Impact factor: 4.799
Authors: Mehrnoosh Saghizadeh; Andrei A Kramerov; Yousha Yaghoobzadeh; Jinwei Hu; Julia Y Ljubimova; Keith L Black; Maria G Castro; Alexander V Ljubimov Journal: Brain Res Bull Date: 2009-10-12 Impact factor: 4.077